« Back
Home /
Human CD30 Monoclonal Antibody

Human CD30 Monoclonal Antibody

Item no.	YR0005-5mg
Manufacturer	Abclonal
Amount	5 mg
Quantity options	1 mg 20 mg 5 mg
Category	ELISA Immunostaining Functional Assays Neutralization
Applications	ELISA, FA, NT
Specific against	other
Isotype	IgG1 Kappa
Purity	>95% Determined by SDS-PAGE
NCBI	CD30
Alias	TNFRSF8,Ki-1,D1S166E
Available
Manufacturer - Applications	ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways
Manufacturer - Category	Biosimilar
Manufacturer - Conjugate / Tag	<5% Determined by SECP
Storage Conditions	2 - 8°C for up to 4 weeks and -80°C for long term storage (Avoid repeated freezing and thawing)
Background	Brentuximab is a biosimilar directed against the extracellular domain of CD30. The brentuximab antibody selectively targets tumor cells expressing the cell membrane protein CD30 and delivers the MMAE, which causes apoptosis by preventing cell cycle progression of the G2 to M phase through disruption of the cytosolic microtuble network, thereby preventing tumor growth and proliferation.
Manufacturer - Cross Reactivity	<1EU/mg (<0.001EU/μg)Determined by LAL gel clotting assay
Route	1×PBS pH 7.0
Gene Symbol	CD30

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

YR0005-5mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Delivery expected until 12/4/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer